Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05202756 · ClinicalTrials.gov registry record · NA
Examining Feasibility, Acceptability, and Sustainability of a Novel Personalized Smartphone Intervention for Suicide - Randomized Trial
A NA study, sponsored by Butler Hospital.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05202756 is a NA study that has completed, run by Butler Hospital. The registered enrollment target is 31 participants.
The verdict
NCT05202756, a NA study, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The primary aim of the present study is leverage existing infrastructure to develop novel technological features for a novel personalized smartphone intervention system, called the Mobile Application to Prevent Suicide (MAPS), and to establish feasibility, acceptability, safety, and estimate key parameters for primary outcomes (i.e., suicidal ideation and behavior; re-hospitalization), and target mechanisms.
Interventions
- BEHAVIORAL Mobile Application to Prevent Suicide (MAPS)
- BEHAVIORAL EMA Monitoring Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2024-06-14 |
| Est. Completion | 2025-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05202756
The ClinicalTrials.gov registry entry for NCT05202756 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mobile Application to Prevent Suicide (MAPS) is the first listed.
NCT05202756 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05202756 about?
NCT05202756 is a clinical study titled "Examining Feasibility, Acceptability, and Sustainability of a Novel Personalized Smartphone Intervention for Suicide - Randomized Trial". The primary aim of the present study is leverage existing infrastructure to develop novel technological features for a novel personalized smartphone intervention system, called the Mobile Application to Prevent Suicide (MAPS), and to establish feasibility, acceptability, safety, and estimate key par...
What is the current status of trial NCT05202756?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2024-06-14. Estimated completion is 2025-12-01.
What interventions are being tested in trial NCT05202756?
The interventions under investigation include: Mobile Application to Prevent Suicide (MAPS) (BEHAVIORAL), EMA Monitoring Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT05202756?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.